Pink Sheet is part of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC’s registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 8860726.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction
UsernamePublicRestriction

INDIGENT CARE MANAGEMENT PROGRAM BY NATIONAL HEALTH COUNCIL/S&FA WOULD LIMIT FINANCIAL EXPOSURE OF INDIVIDUAL MANUFACTURERS; JANUARY DEBUT PLANNED

Executive Summary

The National Health Council is proposing a centrally-administered program for patient drug assistance programs that would provide manufacturers with an option to cap their annual financial exposure. NHC is proposing the program in conjunction with Parexel's S&FA subsidiary, an Alexandria, Va.-based company already participating in the management of individual patient assistance programs.
Advertisement
Advertisement
UsernamePublicRestriction

Register

PS028800

Ask The Analyst

Please Note: You can also Click below Link for Ask the Analyst
Ask The Analyst

Your question has been successfully sent to the email address below and we will get back as soon as possible. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts

Cancel